Estimation of Rezdiffra (MGL-3196) by Validated RP-HPLC Approach in Bulk Material and Pharmaceutical Formulation

Key Points

• The research aims to evaluate a reliable HPLC method for quantifying Rezdiffra in both bulk and pharmaceutical formulations.
• Developed a validated reverse-phase HPLC (RP-HPLC) method.
• Applied the method to bulk material and pharmaceutical formulations.
• Analyzed the results for accuracy and precision.
• Successfully quantified Rezdiffra in various pharmaceutical products.
• Demonstrated the method's effectiveness for quality control in pharmaceuticals.